Selected research
Industry Research
Poultry Vaccines Industry Research Report 2026
Market perspective
The global Poultry Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Poultry Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Poultry Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Poultry Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Poultry Vaccines include Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike and Phibro Animal Health Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Poultry Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Poultry Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Poultry Vaccines Market by Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Poultry Vaccines Segment by Type
Live
Attenuated
Killed
Poultry Vaccines Segment by Application
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
Poultry Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poultry Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poultry Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poultry Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Poultry Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live
- Attenuated
- Killed
Applications
- NDV
- Marek ' s Disease
- IBD
- Infectious Bronchitis
- Influenza
- Others
Companies covered
- Merck
- Boehringer Ingelheim
- Ceva
- Zoetis
- Vaxxinova®
- Elanco
- QYH Biotech Co., Ltd
- Pulike
- Phibro Animal Health Corporation
- JinYu Biotechnology
- Harbin Pharmaceutical Group
- MEVAC
- Venky's
- Japfa Comfeed Indonesia
- Nisseiken
- Hile
- Hester Biosciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Poultry Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Live
- 2.2.3 Attenuated
- 2.2.4 Killed
- 2.3 Poultry Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 NDV
- 2.3.3 Marek ' s Disease
- 2.3.4 IBD
- 2.3.5 Infectious Bronchitis
- 2.3.6 Influenza
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Poultry Vaccines Breakdown Data by Type
- 3.1 Global Poultry Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global Poultry Vaccines Forecasted Market Size by Type (2027-2032)
4 Poultry Vaccines Breakdown Data by Application
- 4.1 Global Poultry Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global Poultry Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Poultry Vaccines Market Perspective (2021-2032)
- 5.2 Global Poultry Vaccines Growth Trends by Region
- 5.2.1 Global Poultry Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Poultry Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 Poultry Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 Poultry Vaccines Market Dynamics
- 5.3.1 Poultry Vaccines Industry Trends
- 5.3.2 Poultry Vaccines Market Drivers
- 5.3.3 Poultry Vaccines Market Challenges
- 5.3.4 Poultry Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Poultry Vaccines Players by Revenue
- 6.1.1 Global Top Poultry Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global Poultry Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global Poultry Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Poultry Vaccines Head Office and Area Served
- 6.4 Global Poultry Vaccines Players, Product Type & Application
- 6.5 Global Poultry Vaccines Manufacturers Established Date
- 6.6 Global Poultry Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Poultry Vaccines Market Size (2021-2032)
- 7.2 North America Poultry Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Poultry Vaccines Market Size by Country (2021-2026)
- 7.4 North America Poultry Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Poultry Vaccines Market Size (2021-2032)
- 8.2 Europe Poultry Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Poultry Vaccines Market Size by Country (2021-2026)
- 8.4 Europe Poultry Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Poultry Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific Poultry Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Poultry Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Poultry Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Poultry Vaccines Market Size (2021-2032)
- 10.2 South America Poultry Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Poultry Vaccines Market Size by Country (2021-2026)
- 10.4 South America Poultry Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Poultry Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa Poultry Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Poultry Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Poultry Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck
- 12.1.1 Merck Company Information
- 12.1.2 Merck Business Overview
- 12.1.3 Merck Revenue in Poultry Vaccines Business (2021-2026)
- 12.1.4 Merck Poultry Vaccines Product Portfolio
- 12.1.5 Merck Recent Developments
- 12.2 Boehringer Ingelheim
- 12.2.1 Boehringer Ingelheim Company Information
- 12.2.2 Boehringer Ingelheim Business Overview
- 12.2.3 Boehringer Ingelheim Revenue in Poultry Vaccines Business (2021-2026)
- 12.2.4 Boehringer Ingelheim Poultry Vaccines Product Portfolio
- 12.2.5 Boehringer Ingelheim Recent Developments
- 12.3 Ceva
- 12.3.1 Ceva Company Information
- 12.3.2 Ceva Business Overview
- 12.3.3 Ceva Revenue in Poultry Vaccines Business (2021-2026)
- 12.3.4 Ceva Poultry Vaccines Product Portfolio
- 12.3.5 Ceva Recent Developments
- 12.4 Zoetis
- 12.4.1 Zoetis Company Information
- 12.4.2 Zoetis Business Overview
- 12.4.3 Zoetis Revenue in Poultry Vaccines Business (2021-2026)
- 12.4.4 Zoetis Poultry Vaccines Product Portfolio
- 12.4.5 Zoetis Recent Developments
- 12.5 Vaxxinova®
- 12.5.1 Vaxxinova® Company Information
- 12.5.2 Vaxxinova® Business Overview
- 12.5.3 Vaxxinova® Revenue in Poultry Vaccines Business (2021-2026)
- 12.5.4 Vaxxinova® Poultry Vaccines Product Portfolio
- 12.5.5 Vaxxinova® Recent Developments
- 12.6 Elanco
- 12.6.1 Elanco Company Information
- 12.6.2 Elanco Business Overview
- 12.6.3 Elanco Revenue in Poultry Vaccines Business (2021-2026)
- 12.6.4 Elanco Poultry Vaccines Product Portfolio
- 12.6.5 Elanco Recent Developments
- 12.7 QYH Biotech Co., Ltd
- 12.7.1 QYH Biotech Co., Ltd Company Information
- 12.7.2 QYH Biotech Co., Ltd Business Overview
- 12.7.3 QYH Biotech Co., Ltd Revenue in Poultry Vaccines Business (2021-2026)
- 12.7.4 QYH Biotech Co., Ltd Poultry Vaccines Product Portfolio
- 12.7.5 QYH Biotech Co., Ltd Recent Developments
- 12.8 Pulike
- 12.8.1 Pulike Company Information
- 12.8.2 Pulike Business Overview
- 12.8.3 Pulike Revenue in Poultry Vaccines Business (2021-2026)
- 12.8.4 Pulike Poultry Vaccines Product Portfolio
- 12.8.5 Pulike Recent Developments
- 12.9 Phibro Animal Health Corporation
- 12.9.1 Phibro Animal Health Corporation Company Information
- 12.9.2 Phibro Animal Health Corporation Business Overview
- 12.9.3 Phibro Animal Health Corporation Revenue in Poultry Vaccines Business (2021-2026)
- 12.9.4 Phibro Animal Health Corporation Poultry Vaccines Product Portfolio
- 12.9.5 Phibro Animal Health Corporation Recent Developments
- 12.10 JinYu Biotechnology
- 12.10.1 JinYu Biotechnology Company Information
- 12.10.2 JinYu Biotechnology Business Overview
- 12.10.3 JinYu Biotechnology Revenue in Poultry Vaccines Business (2021-2026)
- 12.10.4 JinYu Biotechnology Poultry Vaccines Product Portfolio
- 12.10.5 JinYu Biotechnology Recent Developments
- 12.11 Harbin Pharmaceutical Group
- 12.11.1 Harbin Pharmaceutical Group Company Information
- 12.11.2 Harbin Pharmaceutical Group Business Overview
- 12.11.3 Harbin Pharmaceutical Group Revenue in Poultry Vaccines Business (2021-2026)
- 12.11.4 Harbin Pharmaceutical Group Poultry Vaccines Product Portfolio
- 12.11.5 Harbin Pharmaceutical Group Recent Developments
- 12.12 MEVAC
- 12.12.1 MEVAC Company Information
- 12.12.2 MEVAC Business Overview
- 12.12.3 MEVAC Revenue in Poultry Vaccines Business (2021-2026)
- 12.12.4 MEVAC Poultry Vaccines Product Portfolio
- 12.12.5 MEVAC Recent Developments
- 12.13 Venky's
- 12.13.1 Venky's Company Information
- 12.13.2 Venky's Business Overview
- 12.13.3 Venky's Revenue in Poultry Vaccines Business (2021-2026)
- 12.13.4 Venky's Poultry Vaccines Product Portfolio
- 12.13.5 Venky's Recent Developments
- 12.14 Japfa Comfeed Indonesia
- 12.14.1 Japfa Comfeed Indonesia Company Information
- 12.14.2 Japfa Comfeed Indonesia Business Overview
- 12.14.3 Japfa Comfeed Indonesia Revenue in Poultry Vaccines Business (2021-2026)
- 12.14.4 Japfa Comfeed Indonesia Poultry Vaccines Product Portfolio
- 12.14.5 Japfa Comfeed Indonesia Recent Developments
- 12.15 Nisseiken
- 12.15.1 Nisseiken Company Information
- 12.15.2 Nisseiken Business Overview
- 12.15.3 Nisseiken Revenue in Poultry Vaccines Business (2021-2026)
- 12.15.4 Nisseiken Poultry Vaccines Product Portfolio
- 12.15.5 Nisseiken Recent Developments
- 12.16 Hile
- 12.16.1 Hile Company Information
- 12.16.2 Hile Business Overview
- 12.16.3 Hile Revenue in Poultry Vaccines Business (2021-2026)
- 12.16.4 Hile Poultry Vaccines Product Portfolio
- 12.16.5 Hile Recent Developments
- 12.17 Hester Biosciences
- 12.17.1 Hester Biosciences Company Information
- 12.17.2 Hester Biosciences Business Overview
- 12.17.3 Hester Biosciences Revenue in Poultry Vaccines Business (2021-2026)
- 12.17.4 Hester Biosciences Poultry Vaccines Product Portfolio
- 12.17.5 Hester Biosciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst